Director Houghton Michael buys 3,202 shares of ASMB at $15.61 (total $49,997.63); stock -18.8% from 52-week high, company posting -$9.6M net income.
Houghton Michael, a director at Assembly Biosciences, initiated a position of 3,202 shares at $15.61 on 2024-12-30, representing his first recorded holdings in the company. The purchase occurs while the stock trades at $15.78—just 1% above his transaction price—within the lower half of its 52-week range ($9.57–$19.43) and down 18.8% from its 52-week high. The company reported revenue of $6,845,000.00 in the latest quarter against a net loss of $9,613,000.00, with negative full-year net income, indicating ongoing operating losses. The near-exact match to the $50,000 round figure suggests a calculated position sizing, though the modest scale relative to the $100.3M market cap and the context of sustained unprofitability limit the signaling strength of this initial purchase.